Testing effectiveness (Phase 2)Study completedNCT00427349
What this trial is testing
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Eastern Cooperative Oncology Group 46